Welcome to CDC Stacks | Prostate cancer : take time to decide - 24749 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prostate cancer : take time to decide
  • Published Date:
    9/13/13
  • Language:
    English
Filetype[PDF - 982.39 KB]


Details:
  • Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
  • Keywords:
  • Description:
    Who has a higher risk for prostate cancer? -- What is the PSA test? -- What happens next if my PSA is high? -- What are my choices if a biopsy shows early prostate cancer? : Watching it closely, Getting other treatments after talking to your doctor.

    Most prostate cancers grow slowly, and don’t cause any health problems in men who have them. A PSA test may find a prostate health problem. Treatment can cause serious side effects. Take time to ask your doctor these questions before you decide to get tested or treated for prostate cancer

  • Document Type:
    Poster
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Arthritis in America : time to take action!
    Corporate Author:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.); Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communications.;
    Published:
    03/07/2017
    Series:
    CDC Vital signs ; 2017 March
    Description:
    Everyone knows someone with arthritis. It is a leading cause of disability, and causes pain, aching, stiffness, and swelling of the joints, but is not a normal part of aging. The most common types are osteoarthritis, rheumatoid arthritis, gout, lupus...
    File Type:
    Filetype[PDF - 2.96 MB]
  2. Coming Soon
    Immune Therapy for Prostate Cancer
    Personal Author:
    Yeku, Oladapo; Slovin, Susan. F.;
    Published:
    2016 Sep/Oct
    Source:
    Cancer J. 22(5):334-341.
    Description:
    Immunotherapy for castration-resistant prostate cancer has continued to be an area of active research over the last several years. The enthusiasm of this approach has been based on the assumption of better tolerability and that using the body&apo...
    Public Access
    Available on:
    September 01, 2017
  3. Physician behaviors to promote informed decisions for prostate cancer screening: A National Research Network study
    Personal Author:
    Linder, Suzanne K.; Kallen, Michael A.; Mullen, Patricia Dolan; Galliher, James M.; Swank, Paul R.; Chan, Evelyn C.Y.; Volk, Robert J.;
    Published:
    Jun 2014
    Source:
    J Cancer Educ. 29(2):345-349.
    Description:
    Background : Clinical guidelines for prostate cancer screening (PCS) advise physicians to discuss the potential harms and benefits of screening. However, there is a lack of training programs for informed decision making (IDM), and it is unknown which...
    File Type:
    Filetype[PDF - 488.21 KB]
  4. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening
    Personal Author:
    Li, Jun; Zhao, Guixiang; Hall, Ingrid J.;
    Published:
    May 18 2015
    Source:
    Am J Prev Med. 49(2):259-263.
    Description:
    Introduction : For many men, the net benefit of prostate cancer screening with prostate-specific antigen (PSA) tests may be small. Many major medical organizations have issued recommendations for prostate cancer screening, stressing the need for shar...
    File Type:
    Filetype[PDF - 178.57 KB]
  5. Cancer Prevention and Worksite Health Promotion: Time to Join Forces
    Corporate Author:
    Cancer Prevention in the Workplace Writing Group
    Published:
    Jul 24 2014
    Source:
    Prev Chronic Dis. 11.
    File Type:
    Filetype[PDF - 451.60 KB]